We generated novel recombinant influenza A viruses (vNA38) harboring dicistronic NA segments with an extended native 5V terminal sequence of 70 nucleotides comprised of the last 42 nucleotides of the NA ORF and the 5V noncoding region (5V NCR). vNA38 viruses replicated stably and more efficiently than vNA35 viruses with a dicistronic NA segment comprised of the native 5V NCR only, that we described previously (Vieira Machado, A., Naffakh, N., van der Werf, S., Escriou, N., 2003. Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter. Virology 313, 235 -249). In addition, vNA38 viruses drove the expression of higher levels of encoded heterologous proteins than corresponding vNA35 viruses, both in cell culture and in the pulmonary tissue of infected mice. These data demonstrate that a sequence overlapping 5V coding and noncoding regions of the NA segment determines efficient replication and/or propagation of the vRNA. Intranasal immunization of mice with live vNA38 viruses induced B and T cell responses specific for the heterologous protein expressed, establishing the usefulness of such recombinant influenza viruses with a dicistronic segment for the development of live bivalent vaccines. D
Introduction
The genome of influenza A viruses consists of eight molecules of single-stranded RNA of negative polarity. The viral RNAs (vRNAs) are associated with the nucleoprotein (NP) and with the three subunits of the polymerase complex (PB1, PB2 and PA) to form ribonucleoproteins (RNPs). Once released in the infected cells, the RNPs are transported to the nucleus, where they undergo transcription and replication (for a review, see Lamb and Krug, 2001) . The three subunits of the polymerase and the NP are the minimum set of proteins required for both processes, although the molecular mechan-isms involved are clearly different. The initiation of transcription involves a cap-stealing mechanism, by which 5V-capped oligonucleotides derived from cellular mRNA are used as primers and elongated by the viral polymerase (Bouloy et al., 1978; Krug et al., 1979; Plotch et al., 1981) . Termination and polyadenylation occur at a stretch of five to seven U residues close to the 5V end of the template (Luo et al., 1991; Poon et al., 1999; Pritlove et al., 1998) . In the replication process, fulllength positive-stranded RNAs complementary to the vRNAs (cRNAs) are produced, which serve as templates for amplification of the vRNAs. Initiation of the synthesis of cRNAs and vRNAs is primer-independent, and anti-termination occurs at the poly-U sequence during the synthesis of the cRNA (reviewed in Hay, 1998) .
The signals necessary for transcription, replication and packaging of the genome segments have been shown to be located within the 5V and 3V noncoding regions (NCR) of the genomic RNA segments of influenza A viruses, including highly conserved sequences of 13 nucleotides (nt) at the 5V end and 12 nt at the 3V end (Luytjes et al., 1989; Neumann et al., 1994) . The conserved 5V and 3V ends show partial inverted complementarity to each other and interact to form a partially double-stranded ''corkscrew'' structure (Flick et al., 1996) . They are both required for initiation of transcription through interaction with the PB1 subunit of the polymerase complex (Li et al., 1998; Tiley et al., 1994) and constitute the 5V and 3V arm of the vRNA promoter, respectively. In addition, nonconserved sequences of the noncoding regions, 7 to 45 nt in length, were found to modulate the efficiency of transcription/replication (Bergmann and Muster, 1996; Zheng et al., 1996) . Recently, packaging signals of the NA, HA and NS segments were found to be located not only within the NCRs but also in adjacent coding sequences (Fujii et al., , 2005 Watanabe et al., 2003) .
The genome of influenza A viruses codes for 11 proteins. Most genomic segments are monocistronic, except segment PB1 which encodes an additional PB1-F2 protein through the use of an alternate start codon (Chen et al., 2001) , and segments M and NS which encode proteins M2 and NEP in addition to M1 and NS1, respectively, through an alternate splicing mechanism (for a review, see Lamb and Krug, 2001) . Using reverse genetics techniques, several strategies have been explored to generate recombinant influenza viruses expressing additional heterologous proteins (reviewed in Garcia Sastre, 2000) . Some of these strategies are based on the expression of a chimeric viral protein. Recombinant influenza viruses containing an HA with up to 12 aa inserted into the antigenic sites B or E (Gonzalo et al., 1999; Li et al., 1993) or an NA with foreign epitope insertions in the stalk (Castrucci et al., 1992; Efferson et al., 2003; Muster et al., 1995) have been recovered. Other strategies were designed in order to generate recombinant viruses expressing foreign polypeptides as independent proteins. Engineering of a ninth synthetic pseudoviral RNA, containing a foreign ORF in negative polarity flanked by the 5V and 3V NCRs of an influenza segment, resulted in the replication and packaging of this RNA segment into influenza virions (Lu et al., 2004; Luytjes et al., 1989; Neumann et al., 1994) . However, the ninth additional segment expressing a nonessential foreign protein was usually lost upon serial passages. Introduction of mutations in the 3V NCR that conferred a replicative advantage over the other eight virus segments allowed a ninth nonessential segment to be maintained in the viral progeny for more than 10 passages (Neumann and Hobom, 1995; Zhou et al., 1998) . Nevertheless, the proportion of the foreign gene segment still could fluctuate from generation to generation, resulting in variable levels of expression of the corresponding polypeptide. Stable expression of a foreign protein by influenza A viruses was achieved by engineering viral genes encoding fusion proteins or dicistronic genes. Large polypeptides such as the CAT or GFP proteins were stably expressed by influenza A virus vectors as a fusion protein containing an autocatalytic cleavage site or a caspase cleavage site between the viral gene product (usually NA or NS1) and the foreign polypeptide (Ferko et al., 2001; Kittel et al., 2004; Percy et al., 1994) . A drawback of this method is that, due to the remaining of amino acids from the cleavage site, the expression of the viral and/or the foreign protein is altered. Stable expression of a foreign polypeptide by recombinant influenza A viruses has also been achieved by engineering a dicistronic NA segment containing an internal ribosome entry site ''IRES'' . Following transcription of a dicistronic mRNA, translation of the foreign polypeptide and NA protein occurred via capdependent and cap-independent (IRES-mediated) initiation of translation, respectively.
Flick and Hobom introduced a new principle for making an influenza segment dicistronic at the transcription/replication level, by demonstrating that the influenza virus polymerase complex was able to recognize an additional 3V promoter sequence located between two reporter genes in a recombinant vRNA-like molecule (Flick and Hobom, 1999) . Based on their observations, we explored in a previous study the possibility of rescuing recombinant influenza A viruses which harbored a dicistronic NA segment with a foreign gene under the control of a duplicated 3V promoter sequence (Vieira Machado et al., 2003) . Such recombinant viruses (namely, vNA35 viruses) were found to replicate stably both in vitro in cell culture and in vivo in the pulmonary tissue of infected mice. In infected MDCK cells, subgenomic vRNA and mRNA were synthesized under the control of the internal 3V promoter, which resulted in low but significant expression of the foreign gene product (e.g., the CAT protein) in a native form. However, the vNA35 recombinant viruses harboring a dicistronic NA segment showed a reduced growth capacity as compared to the wildtype virus, which was correlated with a reduced expression of the NA protein in infected cells.
In the present study, we tried to improve the characteristics of the vNA35 dicistronic viruses as vectors for the expression of heterologous genes. Based on the observation by Zheng et al. that the noncoding extremities of each segment are specific to the ORFs they contain (Zheng et al., 1996) , we made the hypothesis that some signals important for the replication and/ or propagation of the vRNAs could be disrupted in the vNA35 dicistronic segments, due to the separation of the 5V NCR from the end of the NA coding sequence. Thus, we generated and characterized a new generation of dicistronic viruses named vNA38, similar to the vNA35 viruses except for the fact their NA segments comprise an extended native 5V terminal sequence of 70 nucleotides, as compared to 28 nucleotides for the vNA35 viruses. This was achieved by duplicating the last 42 nucleotides of the NA ORF upstream from the 5V NCR. Meanwhile, Fujii et al. demonstrated that both ends of the NA vRNA coding region were required for incorporation of the NA segment into virions , strongly suggesting a role of the coding sequences in selective packaging of the vRNAs, and thus providing an additional rationale for the design of the vNA38 viruses. Indeed, we found that vNA38 viruses replicated more efficiently than vNA35 viruses, both in cell culture and in the pulmonary tissue of infected mice. In addition, vNA38 viruses drove the expression of higher levels of encoded heterologous proteins than corresponding vNA35 viruses. We demonstrated that intranasal immunization of mice with live recombinant vNA38 viruses was able to induce a B and CD8+ T cell response specific for the expressed heterologous genes.
Results
CAT expression from recombinant dicistronic NA vRNAs conserving 28 nt (vNA35-CAT) or 70 nt (vNA38-CAT) from the wild-type NA vRNA 5V terminal sequence
In an attempt to improve the design of dicistronic influenza A viruses as vectors for the expression of an heterologous protein, we modified the plasmids of the NA35 series described earlier (Vieira Machado et al., 2003) , from which dicistronic influenza vRNA-like molecules can be transcribed by the RNA polymerase I. Plasmid pPR-NA38 was obtained by inserting a duplication of the last 42 nt of the NA ORF between the multiple cloning site (MCS) and the 5V noncoding sequence of the NA segment of WSN in plasmid pPR-NA35 ( Fig. 1) . Subsequently, the three reporter genes that had previously been inserted in the MCS of pPR-NA35 (Vieira Machado et al., 2003) were inserted in the MCS of pPR-NA38: the CAT gene (660 nt), the GFP gene of Aequorea victoria (720 nt) and a sequence coding for a fragment of the VP0 capsid protein of Mengo virus (VP0c, 306 nt). Thus, plasmids of both the pPR-NA35 and pPR-NA38 series direct the synthesis of vRNA-like molecules which contain the NA ORF downstream of the original 3V promoter and a second ORF (CAT, GFP or VP0c) downstream of the duplicated 3V promoter. However, pPR-NA38 derived vRNAs are identical to the wild-type (wt) NA segment of WSN for the 5V terminal 70 nt, whereas the pPR-NA35 derived vRNAs share only the terminal 28 noncoding nt with the wt NA segment.
We examined whether the length of the 5V terminal sequence had an effect on the efficiency with which the dicistronic vRNA molecules were replicated and transcribed by the influenza RNA polymerase complex upon transient reconstitution of vRNPs in vivo. The pPR-NA35-CAT or pPR-NA38-CAT plasmids were transfected into COS-1 cells together with the four pcDNA-PB1, -PB2, -PA and -NP plasmids. Total RNA was extracted 48 h later and analyzed by Northern blot using a positive-sense riboprobe specific for CAT sequences. As shown in Fig. 2A , full-length genomic vRNAs containing NA and CAT sequences (closed arrowheads) and shorter subgenomic vRNAs containing CAT sequences (open arrowheads) were detected at similar levels whether cells had been transfected with the pPR-NA35-CAT or pPR-NA38-CAT plasmid. Genomic and subgenomic cRNAs/mRNAs were synthesized at similar levels from the pPR-NA35-CAT and pPR-NA38-CAT constructs, as revealed when a negative-sense CAT riboprobe was used ( Fig. 2B ). No subgenomic RNA molecules were observed in cells transfected with the control pPR-NA37-CAT plasmid, which lacked the internal 3V promoter sequence (Figs. 1, 2A and B) . Similar results were obtained when the GFP or VP0c reporter genes were used (data not shown). In agreement with what was observed at the RNA level, similar amounts of CAT were measured in cytosolic extracts from cells transfected with the pPR-NA35-CAT or pPR-NA38-CAT plasmids (Fig.  2C ). These results thus showed that the presence of an extended terminal sequence derived from the wt NA segment at the 5V end of the dicistronic NA38-CAT vRNAs did not significantly affect the efficiency with which they underwent both genomic and subgenomic transcription/replication by the influenza polymerase complex expressed transiently, as compared to the NA35-CAT vRNAs.
Characterization of recombinant viruses with dicistronic NA segments of the NA35 and NA38 series
We next compared the efficiency with which recombinant influenza viruses carrying a dicistronic segment could be rescued from plasmids of the NA35 and NA38 series. The various NA35 and NA38 vRNPs were reconstituted in COS-1 cells simultaneously infected with the WSN-HK helper virus, as described by Pleschka et al. (1996) . As observed in our previous study (Vieira Machado et al., 2003) , vNA35-CAT and vNA35-VP0c viruses were recovered at low titers from the supernatant of COS-1 cells (10 1 to 10 2 and 10 2 to 10 3 pfu/ml, respectively), whereas the NA35-GFP dicistronic vRNAs could not be rescued into infectious viruses. In contrast, all three NA38-CAT, NA38-VP0c and NA38-GFP vRNAs were rescued into infectious viruses. Remarkably, titers obtained for vNA38- Fig. 1 . Schematic representation of the plasmids used in reverse genetics experiments for the synthesis of A/WSN/33 virus-derived dicistronic NA segments. Plasmid pPR-NA35 was derived from plasmid pPR-NA, which contains the full-length NA segment of A/WSN/33 virus in negative-sense orientation under the control of a truncated human polI promoter, as described earlier (Vieira Machado et al., 2003) . It contains a recombinant NA segment cDNA, in which the NA coding sequence is followed by a duplicated 3V noncoding region (3V NCR), an XhoI-NheI multiple cloning site (MCS), and the original 5V noncoding region (5V NCR). The pPR-NA37 plasmid was derived from pPR-NA35 by deletion of the duplicated 3V NCR sequence. The pPR-NA38 plasmid was derived from pPR-NA35 by insertion of a duplication of the last 42 nt of the NA ORF (open box) at the NheI restriction site located between the internal 3V NCR and the terminal 5V NCR sequences. The sequences encoding VP0c, CAT and GFP polypeptides were inserted between the XhoI and NheI restriction sites of pPR-NA35 or pPR-NA38, to generate plasmids pPR-NA35-VP0c, -CAT and -GFP, or plasmids pPR-NA38-VP0c, -CAT and -GFP, respectively. P-pol1: truncated human RNA polymerase I promoter (nt À254 to À1). HDV-R: hepatitis y virus genomic ribozyme.
CAT and vNA38-VP0c viruses (10 4 to 10 5 pfu/ml) were close to those obtained for recombinant viruses with a wt NA segment (10 5 to 10 6 pfu/ml).
The recombinant viruses were plaque purified twice on MDBK cells, and the growth properties of several independent clones were examined. First, their plaque phenotype was evaluated in MDCK cells under an agarose overlay in the presence of 2% FCS. Although they were slightly smaller than those observed with the wt vNA or the control vNA38 viruses, plaques formed by the vNA38-CAT and vNA38-VP0c viruses were significantly larger than those formed by their vNA35-CAT and vNA35-VP0c counterparts (Fig. 3A) . The vNA38-GFP virus, however, gave small-sized plaques. In order to compare more precisely the efficiency of multiplication of the vNA35-CAT and vNA38-CAT viruses, their growth kinetics were analyzed on MDCK cells in parallel with those of the vNA, vNA35 and vNA38 viruses. As previously reported, the growth rate of the vNA35-CAT virus was markedly reduced as compared to the wt vNA virus, with titers reaching the level of 10 7 pfu/ml as compared to 10 9 pfu/ml for the wt (Fig. 3B ). In agreement with its larger plaque phenotype, the vNA38-CAT virus grew more efficiently than the vNA35-CAT virus. Titers observed with the vNA38-CAT virus at 48 h post-infection (about 3 Â 10 8 pfu/ml) were intermediate between those observed with the vNA35-CAT and wt vNA viruses and in the same range as those observed for the vNA35 and vNA38 viruses (Fig. 3B) .
The presence of the dicistronic segments was examined for two independent clones of each of the recombinant viruses of the vNA38 series, and their genetic stability was evaluated upon serial passage on MDCK cells at a low m.o.i. RT-PCR was performed on viral RNA extracted from working stocks at passage P1, passage P2 or P3, and at the sixth (P6) passage. Primers NA/+/1085 and NA/NC/5V located in the NA ORF and 5V NCR, respectively, allowed amplification of the whole region of insertion within the NA segment ( Fig. 3C ). PCR products of the expected size were observed for all clones analyzed at P1 (Fig. 3C ). Direct sequencing of the PCR products confirmed that the duplicated 3V NCR and entire foreign sequences (CAT, VP0c or GFP) were present and unmodified as compared to those of the plasmids from which the viruses were derived. The 5V and 3V terminal NCRs of the dicistronic segments were submitted to RACE analysis and appeared to be identical to those of the wild-type vNA virus.
For all clones analyzed except for one of the vNA38-GFP viruses, the inserted sequences were found to be stably retained within the NA segment up to P6 (Fig. 3C ). For vNA38-GFP clone #1, PCR products of a smaller size than expected, corresponding most likely to partial deletions of the GFP sequence, were detectable as soon as P1 and became prominent at P3. In agreement with the genetic instability revealed by RT-PCR analysis, plaques formed by the vNA38-GFP clone #1 virus were heterogeneous and larger in size at P3 as compared to P1 (data not shown). In contrast, the plaque phenotype of the vNA38-GFP clone #2 virus, as well as that of the vNA38-CAT and vNA38-VP0c viruses, remained stable up to P6. Noticeably, trace amounts of an additional DNA fragment, migrating at the same distance as the PCR product amplified from the wt vNA segment, were produced in all amplification reactions ( Fig. 3C ). Because this fragment was also produced in control amplifications performed on the various pPR-NA38 plasmids and showed the same relative intensity after several passages, it most likely represented a PCR artefact rather than a reversion to the wild-type genotype.
CAT and NA expression in cells infected with the vNA35-CAT or vNA38-CAT dicistronic viruses
We next compared the efficiency with which the dicistronic NA segment from vNA35-CAT and vNA38-CAT viruses was replicated and transcribed by the polymerase complex expressed in the course of viral infection. To this end, COS-1 cells were infected at an m.o.i. of 2 with two independent clones of vNA35-CAT or vNA38-CAT or with the control vNA35 or vNA38 viruses. Total RNA was extracted at 24 h post-infection and analyzed by Northern blot. As found earlier in the transient expression assay, genomic and subgenomic vRNAs were detected when a positive-sense CATspecific riboprobe was used ( Fig. 4A) . Similarly, genomic and subgenomic cRNAs/mRNAs were detected when a negative-sense CAT-specific riboprobe was used (Fig. 4B ). The levels of genomic RNAs appeared slightly higher in cells infected with vNA38-CAT as compared to vNA35-CAT. More strikingly, the relative levels of genomic and subgenomic RNAs were inverted: vNA35-CAT subgenomic RNAs were far less represented than the corresponding genomic RNAs, whereas vNA38-CAT subgenomic RNAs were more abundant than the corresponding genomic RNAs (Figs. 4A and B) . Similar results were obtained on MDCK cells and when subgenomic RNAs were compared in vNA38-VP0c and vNA35-VP0c infected cells (data not shown). Next, RNA samples prepared from infected MDCK cells were analyzed for the levels of NAspecific vRNA and c/mRNA, using the NP gene as an internal control (Figs. 5A and B) . Only slight variations of the levels of NP vRNA and cRNA were observed between dicistronic and wt vNA virus-infected cells. In contrast, the levels of NA vRNA and cRNA showed significant variations, depending both on the length of the inserted sequence and on the presence of the last 42 nt of the NA ORF next to the 5V NCR. The length effect was most striking in cells infected with dicistronic viruses of the NA35 series. Indeed, the amount of NA vRNA in vNA35, vNA35-VP0c and vNA35-CAT infected cells represented 36, 17 and 3%, respectively, of the amount of vRNA detected in wt vNA-infected cells (Fig. 5A ). On the other hand, much higher levels of NA vRNAs were found in cells infected with the vNA38-CAT as compared to the vNA35-CAT virus (22% of the levels associated with vNA infection, as compared to 3%). Such an increase was also observed when the vNA38 and vNA35 viruses were compared but not when the vNA38-VP0c and vNA35-VP0c viruses were compared ( Fig. 5A ). Variations of the levels of NA cRNA followed very much the same pattern as observed for the NA vRNA (Fig. 5B ).
The production of CATand NA proteins was then compared in cells infected with the vNA35-CAT or vNA38-CAT viruses. Amounts of CAT were measured by ELISA in cytosolic extracts prepared from COS-1 cells at 8 or 24 h post-infection and were found to be more than 2 logs higher in vNA38-CAT infected cells than in vNA35-CAT infected cells. As shown in Fig. 4C , levels of CAT produced upon infection with vNA38-CAT and vNA35-CAT were 400 T 20 ng/10 6 cells and 1.1 T 0.7 ng/10 6 cells, respectively, at 8 h post-infection, and they increased to 5400 T 470 ng/10 6 cells and 12 T 5 ng/10 6 cells, respectively, at 24 h postinfection. Similar results were obtained on MDCK cells and when production of the VP0c polypeptide was compared in vNA38-VP0c and vNA35-VP0c infected cells (data not shown). Expression of NA at the cell surface was examined by FACS analysis performed on MDCK cells at 8 h post-infection. As shown in Fig. 5C , MDCK cells infected with the control vNA35 or vNA38 viruses expressed the same amounts of NA as compared to cells infected with the wt vNA virus, whereas expression of the NA was reduced in cells infected with dicistronic viruses. However, the reduction was significantly lower in cells infected with vNA38-CAT (34%) as compared to vNA35-CAT (71%). A similar observation was made when comparing MDCK cells infected with the vNA38-VP0c or vNA35-VP0c viruses, as they expressed 28% and 55% less NA, respectively, than cells infected with the vNA virus ( Fig. 5C ).
On the whole, our results showed that expression of the NA, CAT and VP0c proteins was higher in cells infected with the vNA38-CAT or vNA38-VP0c as compared to the vNA35-CAT or vNA35-VP0c viruses, respectively, which correlated with a strong increase in the synthesis of the subgenomic RNA species and, in some cases, with a moderate increase in the synthesis of the genomic RNA species.
Packaging of the vNA38-CAT subgenomic RNAs into viral particles
We asked whether the subgenomic vRNAs that appeared to be efficiently replicated in cells infected with the vNA38-CAT virus were packaged into viral particles and propagated along with the 8 genomic segments. MDCK cells were infected with the vNA38-CAT virus at an m.o.i. of 0.01. The supernatant was collected 72 h later, clarified and fractionated on a sucrose gradient as described under Materials and methods. RNA was extracted from each fraction and analyzed by Northern blot using a positive-sense CAT riboprobe. As shown in Fig. 6A , the peak of detection of an RNA species corresponding in size to the full-length NA38-CAT genomic vRNA (closed arrowhead) coincided with fractions 7 to 10, the highest amounts being detected in fraction 9. The presence of a smaller RNA species corresponding in size to the subgenomic CAT vRNA (open arrowhead) was also detected in fractions 7 to 10, the relative amount of the large and small RNA species being conserved from one fraction to another. In parallel, the infectious titer of each fraction of the gradient was determined by plaque assay, and a co-sedimentation of infectious particles with genomic and subgenomic RNAs was clearly observed (Fig. 6B) . In order to confirm that the subgenomic vNA38-CAT RNAs were packaged into viral particles, fraction 9 was submitted to dialysis and divided into aliquots that were either treated with S7 nuclease, with Triton X100, with S7 nuclease and Triton X100 simultaneously or mock-treated. RNA was extracted from the treated samples, as well as from an aliquot of fraction 9 left untreated, and analyzed by Northern blot as described above. The result is shown in Fig. 6C . The amounts of genomic and subgenomic RNAs were identical in the untreated and mock-treated samples and in the samples that had been treated with the S7 nuclease or Triton X100 alone. Only if performed in combination with the Triton X100 extraction did the S7 nuclease digestion result in complete disappearance of the genomic and subgenomic RNAs. The most straightforward interpretation of this result is that solubilization of the viral envelope with Triton X100 was required for RNAs to become accessible to the nuclease. Thus, our data strongly suggest that both the genomic and subgenomic vNA38-CAT RNAs were packaged into viral particles.
Viral replication and expression of an heterologous protein in mice inoculated with dicistronic viruses of the vNA38 series.
Comparison of vNA35-CAT and vNA38-CAT
In order to compare the potential of dicistronic viruses of the NA35 and NA38 series to replicate in the respiratory tract of mice, male C57BL/6 mice were inoculated intranasally with 10 3 pfu of wt vNA virus, dicistronic vNA35-CAT or vNA38-CAT virus. An independent experiment with a similar design was performed to test the vNA38-VP0c virus, in parallel with the vNA and vNA38 viruses.
According to previous experiments, 10 3 pfu of the vNA virus which corresponded to 0.1 LD50 induced a nonlethal viral pneumonia in more than 95% of the infected mice (Vieira Machado et al., 2003) . Indeed, in mice inoculated with the vNA virus, as well as in mice inoculated with the vNA38, vNA38-CAT or vNA38-VP0c virus, and to a lower extent in mice inoculated with the vNA35-CAT virus, the lungs harvested at 4 days post-inoculation (p.i.) showed macroscopic lesions typical of viral pneumonia. At 7 days p.i., the lungs of vNA and vNA38-CAT infected mice showed a broad hepatized aspect, whereas the lung lesions of vNA35-CAT infected mice remained scattered (data not shown). At 4 days p.i., pulmonary viral loads in mice infected with vNA38-CAT were slightly reduced as compared to vNA-infected mice (5.5 T 0.3 versus 6.1 T 0.1 log 10 pfu/lungs, P 0.01, Fig. 7A ). Similarly, viral loads found in mice infected with vNA38-VP0c were slightly lower at 4 days p.i. (a less than 0.5 log 10 reduction was observed, P < 0.02, Fig.  7B ). At 7 days p.i., viral loads in mice infected with vNA38-CAT remained high and were not significantly different from those measured in mice infected with the vNA virus (5.7 T 0.4 versus 6.1 T 0.3 log 10 pfu/lungs, P = 0.1, Fig. 7A ). In contrast, pulmonary viral loads in mice infected with vNA35-CAT kept decreasing from day 4 (4.1 T 0.7 log 10 pfu/lungs) to day 7 p.i. (3.3 T 0.4 log 10 pfu/lungs), underlining the attenuated phenotype of this virus in mice. On the whole, these results suggested that dicistronic viruses of the vNA38 series could replicate in the lower respiratory tract of mice more efficiently than vNA35 viruses and almost as efficiently as the wt virus, which was in agreement with the growth curves observed in cell culture.
The genome of the viruses recovered from the lung homogenates was analyzed by RT-PCR, using primers NA/+/1085 and NA/NC/5V as mentioned above. As indicated by the size of the PCR products, both vNA-38-CAT ( Fig. 7C ) and vNA-38-VP0c (Fig. 7D ) retained the foreign inserted sequences upon multiplication in the respiratory tract of mice, thus showing that dicistronic viruses of the vNA38 series were genetically stable in vivo. pfu/ml) in the indicated fractions were determined on MDCK cells, using a standard plaque assay. (C) Fraction 9 was submitted to dialysis, and aliquots were subsequently treated with Triton X100, with S7 nuclease, or with both simultaneously, as described under Materials and methods. Control aliquots were mock treated or left untreated. RNA was extracted from the various aliquots and analyzed by Northern blot for the presence of genomic (closed arrowheads) and subgenomic (open arrowheads) vRNAs, as described above.
We next examined whether such viruses allowed detectable expression of an heterologous protein in vivo. Mice were inoculated with 10 5 pfu of either the vNA35-CAT or vNA38-CAT virus, and CAT levels were measured by ELISA in lung homogenates prepared at 4 days post-inoculation. As shown in Fig. 7E , CAT could not be detected in the lungs of mice inoculated with vNA35-CAT ( 0.19 ng/lungs), whereas a significant expression of CAT (21.6 T 4.2 ng/lungs) was observed in the lungs of mice inoculated with vNA38-CAT. These observations suggest that during their multiplication in mice, dicistronic viruses of the vNA38 series allow subgenomic vRNAs to be replicated and transcribed and an heterologous protein to be synthesized in the infected pulmonary tissues.
Induction of humoral and cellular immune responses in mice inoculated with dicistronic viruses of the vNA38 series. Comparison of vNA35-CAT and vNA38-CAT immunogenicity
We examined further whether an immune response against the heterologous CAT or VP0c protein could be generated in Fig. 7 . Multiplication of recombinant viruses with NA38 dicistronic segments in mice and expression of an heterologous protein in vivo. Groups of six (A) or five (B) C57BL/6 mice were infected intranasally with 10 3 pfu of the indicated viruses. Four or seven days after inoculation, mice were euthanized, and lung homogenates were prepared and titrated for infectious virus by plaque assay on MDCK cells. Viral titers were expressed as log 10 (pfu/lungs) for individual mice. The titration limit is indicated by the dotted line. (C, D) Viral RNAs from the inoculated viruses (inoc.) or from viruses recovered from the lungs of individual mice (#1 -6) were extracted and analyzed by RT-PCR using the NA/+/1085 and NA/NC/5V oligonucleotide primers, as in Fig. 3 . The amplified products were analyzed on a 1% agarose gel and visualized by ethidium bromide staining. M: molecular weight markers; the size (kb) is indicated on the side. Mock: amplification of RNA from mock-infected mice. (E) C57BL/6 mice were infected intranasally with 10 5 pfu of vNA, vNA35-CAT or vNA38-CAT viruses as indicated. Four days later, lung homogenates from individual mice were assayed for CAT expression. Levels are expressed in nanograms of CAT protein per lungs. The detection limit (0.19 ng of CAT/lungs) is indicated by the dotted line. mice upon inoculation of the vNA38-CAT or vNA38-VP0c virus. C57BL/6 mice were inoculated intranasally with 10 3 pfu of vNA35-CAT, vNA38-CAT, or vNA38-VP0c, or control vNA or vNA38 virus. Sera were sampled at 3 weeks postinoculation and tested for the presence of anti-influenza antibodies by ELISA. High antibody titers were found in mice inoculated with the wt virus and in mice inoculated with the dicistronic vNA38 viruses as well, indicating that expression of an heterologous protein by the vNA38-CAT and vNA38-VP0c viruses did not modify their influenza-specific immunogenicity (Figs. 8A and C) . In accordance with their reduced replication rate in vivo, significantly lower antibody titers were found in mice inoculated with the vNA35-CAT virus (5.2 T 0.2 versus 5.8 T 0.2 log 10 titer, P < 0.01).
Sera harvested from mice inoculated with the vNA, vNA35-CAT or vNA38-CAT viruses were also tested for the presence of anti-CAT antibodies. As shown in Fig. 8B , moderate but significant titers of anti-CAT antibodies were measured in 6 out of 8 mice inoculated with vNA38-CAT, whereas a single out of 7 vNA35-CAT-inoculated mice showed only low levels of anti-CAT antibodies.
Induction of an heterospecific cellular response was examined in mice that had been inoculated with the vNA38-VP0c or vNA38 viruses. Spleen cells harvested at 2 months post-inoculation were tested by ELISPOT for the presence of Mengo virus-specific CD8+ T lymphocytes, using the Mengo-virus VP2 121 -130 immunodominant H-2D b peptide (Dethlefs et al., 1997) . IFNg-producing T cells were detected in response to the VP2 121 -130 peptide when splenocytes were isolated from all six vNA38-VP0c inoculated mice but not from four control vNA38 inoculated mice (Fig. 8D ). Mengovirus-specific T cell precursor frequencies ranging between 8 and 23 per 10 6 splenocytes (average 17 T 6) were observed in vNA38-VP0c infected mice, as compared to less than 1 per 10 6 splenocytes in control mice (average 0.8 T 0.4), demonstrating that a modest but significant heterospecific CD8+ T cell response was induced upon infection with the vNA38-VP0c virus.
Discussion
Based on observations from Flick and Hobom (1999) , we showed previously that it was possible to have a foreign gene expressed by stable recombinant influenza viruses harboring a dicistronic NA segment with an internal duplicated 3V promoter (vNA35 viruses) (Vieira Machado et al., 2003) . Here, we describe a second generation of dicistronic influenza viruses with improved characteristics as vectors for the delivery of heterologous proteins, called vNA38 viruses. The dicistronic NA segments from the vNA38 as well as vNA35 viruses contain the NA ORF downstream of the original 3V promoter and a second ORF (CAT, GFP or VP0c) downstream of the duplicated 3V promoter. The two types of viruses differ only in Fig. 8 . Anti-influenza and anti-CAT antibody response and Mengovirus-specific CD8+ T cells response in mice infected with dicistronic vNA38 viruses. C57BL/6 mice were inoculated intranasally under light ketamine anesthesia with 10 3 pfu of the indicated recombinant viruses. Sera were collected 3 weeks after inoculation. Antibody titers are represented as the reciprocal of the highest dilution of each serum sample giving an optical density equal to five times that of background levels in an ELISA test using purified split influenza A/PR/8/34 (A, C) or purified CAT protein (B) as antigen. The limits of detection are indicated by the dotted line. (D) Splenocytes from mice infected with vNA38 or vNA38-VP0c viruses were harvested 2 months after inoculation and assayed for the presence of Mengovirus-specific IFNg-producing T cells by ELISPOT using the immunodominant VP2 121 -130 peptide, as described under Materials and methods. the length of the sequences remaining identical to the wild-type NA segment of WSN at the 5V end, i.e., 70 nt for the vNA38 viruses, instead of the 28 noncoding nt only for the vNA35 viruses. The recombinant vNA38-CAT and -VP0c viruses showed an improved capacity of multiplication in vitro as compared to their vNA35-CAT and -VP0c counterparts. This improvement could be correlated with higher steady-state levels of NA vRNA, c/mRNAs and protein, in cells infected with the vNA38-CAT and -VP0c viruses as compared to the vNA35-CAT and -VP0c viruses, respectively. Recombinant vNA38-GFP viruses could be rescued, whereas attempts to rescue vNA35-GFP viruses remained unsuccessful. However, vNA38-GFP viruses grew to lower titers and formed smaller plaques as compared to the vNA38-CAT and -VP0c viruses. This reduced growth capacity could be due to the larger size (720 nt, as compared to 660 and 306 nt for CAT and VP0c, respectively) or to the nature, such as the higher GC content (62%, as compared to 45 and 48% for CAT and VP0c, respectively), of the GFP insert, as previously discussed (Vieira Machado et al., 2003) . Indeed, the GC content of the WSN genome segment is 43.9 T 1.5% and sequences with a significantly higher GC content may not be efficiently replicated by the viral polymerase. Such differences in GC content could also account for the findings by Lu et al. and Kittel et al. that recombinant influenza viruses carrying the GFP sequences within the NS segment are unstable upon multiple passages in cell culture (Kittel et al., 2004; Lu et al., 2004) . Except for one vNA38-GFP clone, all the recombinant dicistronic viruses of the vNA38 series were found to be stable, as they did not show mutations in noncoding sequences of the NA segment and retained the inserted sequences upon serial passages in cell culture. However, mutations in the NA ORF (resulting in an increased activity of the NA) or the HA ORF (resulting in a decreased dependence on NA activity) may have been selected if they could compensate for the slightly reduced synthesis of NA by the recombinant vNA38 viruses as compared to the wt (Gubareva et al., 1996) .
Production of the foreign CAT polypeptide was more than 2 logs higher in cells infected with the vNA38-CAT virus than in cells infected with its vNA35 counterpart. The levels of CAT subgenomic vRNAs and c/mRNAs were also dramatically increased in cells infected with vNA38-CAT as compared to vNA35-CAT, whereas the levels of NA-CAT genomic vRNAs and c/mRNAs were only slightly higher. Similar observations were made when production of the VP0c polypeptide was compared in vNA38-VP0c and vNA35-VP0c infected cells. In contrast, no GFP expression and no subgenomic RNAs could be detected in cells infected with the vNA38-GFP virus (data not shown). GFP expression could be detected, however, upon transient reconstitution of vRNPs in COS-1 cells with either the NA38-GFP segment or a 38-GFP minigenome corresponding to its subgenomic vRNA (data not shown). This observation further suggested that in the context of viral infection, the NA38-GFP vRNA sequence may not efficiently compete with wild-type segment for replication by the viral polymerase. On the whole, our results indicate that the level of expression of the transgene located downstream the internal duplicated 3V promoter is correlated to the level of synthesis of the subgenomic RNAs. Although size and/or sequence limitations might occur, as suggested by the absence of GFP protein expression in vNA38-GFP infected cells, vNA38 viruses appear as improved vectors for gene delivery as compared to vNA35 viruses. They offer a large coding capacity and the possibility to express native proteins devoid of additional sequences, as do vNA35 viruses and as discussed previously (Vieira Machado et al., 2003) , but they allow much higher levels of expression of the transgene to be achieved.
How could improved growth properties and increased expression of the transgene relate to the fact that the dicistronic segment harbored 5V end sequences identical to that of the wt NA over 70 nt for vNA38 viruses, instead of 28 nt for vNA35 viruses? We found that this difference in the length of the 5V terminal sequence had no effect on the efficiency with which genomic and subgenomic RNA molecules were replicated and transcribed by the influenza RNA polymerase complex upon transient reconstitution of vRNPs in COS-1 cells. We cannot rule out that this transient assay might fail to reveal putative transcription/replication defects of the NA35 constructs, due to the lack of competition of the dicistronic NA segments with wild-type segments. However, given the finding by Fujii et al. that both ends of the NA coding region are required for incorporation of the NA segment into virions , the most likely interpretation of our data is that the presence of an extended 70 nt long 5V end sequence including the last 42 nt of the NA ORF in addition to the 28 nt of the 5VNC region in the vNA38 dicistronic segments promotes efficient packaging of these segments into viral particles and thus efficient propagation of the vNA38 recombinant dicistronic viruses. Indeed, using an influenza minigenomes/helper virus system, we could demonstrate that the NA ORF last 42 nt specifically and efficiently promote packaging of genomic vRNA-like molecules (Leclercq et al., manuscript to be submitted). Moreover, our analysis of the RNAs extracted from sucrose gradient-purified virions strongly suggested that not only the genomic but also the subgenomic vNA38-CAT vRNAs were efficiently packaged into viral particles. This finding probably accounts for the differences observed in the relative levels of genomic versus subgenomic RNAs between cells infected with vNA38-and vNA35-CAT viruses. Our hypothesis is that little or no subgenomic vRNAs are delivered by infectious vNA35-CAT particles. According to this hypothesis, the subgenomic vRNAs detected in vNA35-CAT infected cells are mainly generated by internal initiation events involving interaction of the 5V promoter with the internal 3V promoter sequence and subsequent amplification by the viral polymerase. Similarly, subgenomic mRNAs may either be generated from internal initiation reactions during transcription of genomic vRNAs or result from the transcription of subgenomic vRNAs. The ratio of subgenomic to genomic RNAs in vNA35-CAT infected cells was low, suggesting that internal initiation by the polymerase complex was unfrequent in the course of viral infection. In contrast, in vNA38-CAT infected cells, subgenomic RNAs were much more abundant than genomic RNAs, which probably resulted from two factors.
First, packaged subgenomic RNAs were delivered by vNA38-CAT infectious particles and could thus be present in the nucleus of infected cells independently of the occurrence of internal initiation reactions. Second, subgenomic RNAs likely underwent preferential amplification by the polymerase complex due to their small size, as compared to the genomic RNAs. The question remains whether subgenomic RNAs are packaged into viral particles as a ninth segment (as already shown to occur, Enami et al., 1991) or whether they compete specifically for packaging with the genomic dicistronic RNAs (as suggested by previous observations on defective viral RNAs, Duhaut and Dimmock, 2002; Odagiri and Tashiro, 1997) .
The vNA38-CAT and vNA38-VP0c viruses proved to replicate efficiently and to be stable not only in MDCK cell culture but also in vivo in the pulmonary tissue of infected mice. In vNA38-CAT inoculated mice, moderate levels of CAT protein and anti-CAT antibodies were measured in the lungs and serum, respectively. In agreement with its reduced growth and expression capacity in vitro, vNA35-CAT had an attenuated phenotype and was far less immunogenic in mice. In vNA38-VP0c inoculated mice, a modest but significant Mengo virus-specific CD8+ T cell response was detected. In these experiments, the intensity of the immune responses might have been limited by the low level of expression of the heterologous protein in the lung of mice and/or by the low antigenicity of these antigens. Using well-characterized antigens, such as the HBS surface antigen of hepatitis B virus or the nucleoprotein of LCMV virus, could help in evaluating the induction of a protective immune response of humoral or cellular nature, respectively, by vNA38 dicistronic viruses. These studies are currently in progress. If applied to attenuated influenza viruses (such as the cold-adapted strain which has recently been used as a live-attenuated influenza vaccine, Belshe et al., 2004) , the dicistronic approach could potentially be used as a new strategy for vaccination against respiratory or other pathogens for humans. To this end, it could also be of interest to engineer dicistronic vRNA molecules from another segment than the NA (or HA) segment. This would alleviate the need for engineering dicistronic NA segments from each new vaccine strain and would allow the use of various influenza virus subtypes for efficient prime-boost immunizations (Ferko et al., 2001) or in order to circumvent any preexisting immunity to the vector. The NS segment would be a good candidate because (a) a greater coding capacity can be expected from its smaller size; (b) the packaging signals specific for the NS segment have been recently described (Fujii et al., 2005) ; (c) deletion of the sequences encoding NS1 has been shown to confer an attenuated phenotype Garcia Sastre et al., 1998) and would also help avoid interference between the alternative splicing of the mRNA required for the expression of the NEP protein and the transcription of subgenomic RNAs required for expression of the foreign protein. Such a dicistronic attenuated influenza virus could represent an alternative expression vector, in addition to the neuraminidase-deficient influenza A viruses recently described by Shinya et al. and Mishin et al. , that have a great coding capacity but allow expression of foreign proteins as fusion polypeptides with the 61 or 56 N-terminal residues of the NA, respectively (Mishin et al., 2005; Shinya et al., 2004) . Which vector would successfully achieve the optimal balance between attenuation, safety and immunogenicity will have to be determined experimentally in suitable models.
Materials and methods

Cells and viruses
MDBK and MDCK cells were grown at 37 -C under 5% CO 2 in complete Dulbecco's modified Eagle medium (DMEM), supplemented with 5% heat-inactivated fetal calf serum (FCS). COS-1 cells were grown in DMEM supplemented with 10% FCS.
Influenza virus A/WSN/33 (WSN, H1N1) and the WSN/HK (H1N2) reassortant were kindly provided by Dr. Peter Palese (Mount Sinaï School of Medicine, New York, USA). Viral stocks were produced by serial allantoic passage on 11-day-old embryonated hen's eggs.
Plasmids
For reverse genetics, cDNAs corresponding to the wild-type or recombinant NA segments of the WSN influenza virus were cloned in negative-sense polarity into plasmid pPR7 (Crescenzo-Chaigne et al., 1999) , under the control of the human RNA polymerase I promoter and the hepatitis y ribozyme. Plasmids pPR-NA, as well as plasmids of the pPR-NA35 and pPR-NA37 series, have been described in detail earlier (Vieira Machado et al., 2003) .
To generate plasmid pPR-NA38, the 5V end of the NA segment was amplified using plasmid pPR-NA as a template, and oligonucleotides 5V-GACGCTAGCTGGCCAGACGGTGCT-GAGTTGCCGTTC-3V and 5V-GTGAGCGGATAACAATTT-CACAC-3V. The PCR product was cloned between the NheI and HindIII sites in plasmid pPR-NA35. As a result, pPR-NA38 contains a cDNA corresponding to a recombinant NA segment, where the NA ORF is followed by a duplicated 3V NCR, an XhoI-NheI multiple cloning site, a duplication of the last 42 nucleotides of the NA ORF, and the 5V NCR (Fig. 1) . Plasmids pPR-NA38-CAT, pPR-NA38-GFP and pPR-NA38-VP0c were obtained by subcloning the sequences encoding the CAT protein, GFP protein and VP0c fragment corresponding to 157 -249 aa of the Mengovirus VP0c polypeptide, respectively, between the XhoI and NheI sites of plasmid pPR-NA38, as described earlier for plasmids of the pPR-NA35 series (Vieira Machado et al., 2003) . All constructs were verified by the sequencing of positive clones using a Big Dye terminator sequencing kit and an ABI377 automated sequencer (Perkin-Elmer).
Production of recombinant viruses by reverse genetics
Production of recombinant viruses by reverse genetics was performed by transfecting each of the pPR-NA, pPR-NA35 or pPR-NA38 plasmids into COS-1 cells, together with expres-sion plasmids for the PB1, PB2, PA and NP proteins, and by superinfecting the transfected cells with the WSN/HK helper virus, as described previously (Vieira Machado et al., 2003) . The recovered viruses were amplified once on MDCK cells and then plaque purified twice on MDBK cells before final amplification on MDBK cells (viral stock P1). Subsequent passages (P2, P3) of the recombinant viruses were performed at an m.o.i. of 0.01 on MDCK cells for 3 days at 35 -C in DMEM supplemented with 2% FCS. All viral stocks were titrated on MDCK cell monolayers, in a standard plaque assay using an agarose overlay in DMEM with 2% FCS.
Analysis of CAT expression in transfected or infected cells
For the transient expression assay, COS-1 cells were cotransfected with plasmids pPR-NA35-CAT, pPR-NA37-CAT or pPR-NA38-CAT, together with plasmids providing expression of the PB1, PB2, PA and NP proteins, as described earlier (Vieira Machado et al., 2003) . Alternatively, confluent monolayers of MDCK cells were infected with the wt vNA or recombinant vNA35 and vNA38 influenza viruses at an m.o.i. of 2. Cell extracts were prepared in 500 Al of lysis buffer, either at 24 and 48 h post-transfection or at 8 and 24 h post-infection, and were tested for CAT levels using the CAT ELISA kit (Roche). The lower limit of CAT detection was 0.05 ng/ml.
Analysis of NA expression in infected cells
MDCK cells grown in 35-mm dishes were infected with the wt or recombinant WSN viruses at an m.o.i. of 2. Surface expression of the NA was analyzed at 8 h post-infection by an indirect immunofluorescence assay, using the mouse monoclonal antibody 10C9 which is specific for the WSN-NA protein (kindly provided by Dr. Peter Palese) and a FACScalibur fluorocytometer (Becton-Dickinson), as described earlier (Vieira Machado et al., 2003) .
Viral RNA extraction, RT-PCR, sequencing and RACE analysis
Viral RNA was extracted with Trizol-LS reagent (Invitrogen) from 250 Al of cell-free supernatant according to the manufacturer's recommendations. The RNA was resuspended in 20 Al of RNAse-free water, and 5 Al was used for reverse transcription and PCR amplification using primers NA/+/1085 (spanning NA cDNA nucleotides 1085-1108) and NA/NC/5V (complementary to nucleotides 1385 -1409) as previously described (Vieira Machado et al., 2003) . A fraction of the RT-PCR products was analyzed on a 1% agarose gel and visualized by ethidium bromide staining. The remaining was purified using a QIAquick PCR purification kit (Qiagen), and the nucleotide sequence was determined using internal oligonucleotides, a Big Dye terminator sequencing kit and an ABI377 automatic sequencer (Applied Biosystems).
Sequencing of the 5V termini of the NA genomic RNA segment was performed using an oligonucleotide/cDNA ligation strategy. Briefly, viral RNA was submitted to reverse transcription using as primers oligonucleotides of positive polarity specific of the CAT, VP0c, GFP or NA coding sequences. The resulting cDNAs were ligated to a phosphorylated oligonucleotide tag with an amino group on the 3V terminus using the T4 RNA ligase, and a fraction of the ligation reaction was used as a template for a nested PCR amplification as described previously (Vieira Machado et al., 2003) . For sequencing of the 3V termini, viral RNA was poly-adenylated using the yeast poly(A) polymerase. Complementary DNAs were prepared by reverse transcription of the poly-adenylated RNAs using an anchored oligo-dT primer, and PCR amplification was carried out, as described earlier (Vieira Machado et al., 2003) . The amplified products corresponding to the 5V and 3V termini of the NA segment were sequenced with internal oligonucleotides, as described above.
Northern blot analysis
COS-1 cells grown in 35-mm dishes were transfected as described above. MDCK cells were infected with recombinant or wild-type vNA viruses at an m.o.i. of 2. At 24 h post-infection or 48 h post-transfection, total cellular RNAs were isolated by Trizol extraction (Invitrogen) according to the manufacturer's recommendations. When RNA was prepared from transfected cells, RNA extraction was followed by digestion with 20 units of DNase I (Ambion) in 60 Al of 10 mM Tris -HCl pH7.5, 2.5 mM MgCl 2 , 0.1 mM CaCl 2 for 60 min at 37 -C, phenol extraction and isopropanol precipitation.
After denaturation at 70 -C in 50% formamide, 2.2 M formaldehyde, 1Â running buffer (40 mM MOPS, 10 mM sodium acetate, 2 mM EDTA, pH 7.0), samples (2 Ag) were run on a 1.2% agarose -0.6 M formaldehyde gel, blotted onto a nylon membrane (Hybond N, Amersham) and hybridized with a NA-, GFP-, VP0c-or CAT-specific 32 P-labeled riboprobe allowing the detection of RNAs of either negative (vRNAs) or positive (cRNAs, mRNAs) polarity. Hybridizations and membrane washes were performed as previously described (Vieira Machado et al., 2003) . Finally, membranes were exposed on a STORM 820 phosphorimager (Molecular Dynamics) and analyzed using the Image Quant program (Molecular Dynamics).
Analysis of the packaging of subgenomic RNAs into viral particles
Confluent monolayers of MDCK cells were infected with the vNA38-CAT virus at an m.o.i. of 0.01. The cell supernatant was collected 24 h later and clarified by two successive centrifugations at 3000 g. A fraction of the cell-free supernatant (2.5 ml) was then loaded onto a 10 ml 15 -40% sucrose (w/v) gradient in TNE buffer (0.01 M Tris -HCl, pH 7.4; 0.15 M NaCl; 0.1 mM EDTA) and centrifuged for 50 min at 25,000 rpm in a TST 41.14 rotor. Subsequently, 16 fractions were collected from the bottom of the gradient. The viral titers of each fraction were evaluated by a standard plaque assay as described above. In parallel, RNA was extracted from each fraction and analyzed by Northern blot in order to detect the presence of genomic and subgenomic vRNAs, as described above. The fraction characterized by both the highest vRNA content and the highest infectious titer was dialyzed for 4 h in TN buffer (0.01 M Tris -HCl, pH 7.4; 0.15 M NaCl). After CaCl 2 was added to a final concentration of 1mM, 80 Al aliquots of the dialyzed fraction was treated for 30 min at 20 -C either with Triton X100 0.05%, or with S7 nuclease 2 AM (Amersham), or with both simultaneously. After the treatment was stopped by addition of 3 mM EGTA, RNAs were extracted and analyzed by Northern blot as described above.
Infection of mice
Male C57BL/6 mice (Charles River France) 7 to 8 weeks of age were anesthetized lightly with 100 mg/kg of ketamine (Merial) and inoculated intranasally with 10 3 or 10 5 pfu of wild-type or recombinant virus in 40 Al of PBS. At 4 days postinfection, mice were sacrificed, and lung homogenates were prepared in PBS (3 ml) and titrated for virus on MDCK cell monolayers, in a standard plaque assay. Statistical analyses were performed on the log 10 of the viral titers measured for individual mice using the Student's independent t test, with the assumptions used for small samples (normal distribution of the variable, same variance for the populations to be compared). Viral RNA was extracted with Trizol-LS reagent (Invitrogen) from 250 Al of lung homogenates and analyzed by RT-PCR, as described above. Alternatively, viral RNA was extracted using the QIAamp Viral RNA Mini kit (Qiagen) from 140 Al of lung homogenates, eluted in 50 Al of RNAse-free water and analyzed by RT-PCR using the Titan One Tube RT-PCR System (Roche) and the NA/+/1085 and NA/NC/5V primers. The concentration of CAT protein in lung homogenates was determined by ELISA. Briefly, 300 Al of lung homogenates was centrifuged for 5 min at 15,000 g at 4 -C. Supernatants were collected, mixed with equal volumes of lysis buffer and tested for CAT levels using the CAT ELISA kit (Roche). The lower limit of CAT detection was 0.15 ng/lung.
Determination of antibody titers by ELISA
Blood from mice was collected 3 weeks after virus inoculation. Serial dilutions of serum samples were tested to determine influenza virus-specific and CAT-specific antibody titers by indirect ELISA, using 0.5 Ag of detergent-disrupted purified A/PR/8/34 virus or 0.25 Ag of purified CAT protein (Sigma) per well, respectively, as antigen. Briefly, 96-well ELISA plates (NUNC Maxisorp) were coated with the antigen in 0.2 M Na-carbonate, pH 9.6. Following incubation with the serum samples diluted in PBS -BSA 1% -Tween 20 0.1%, bound antibodies were detected by successive incubations with peroxidase-linked sheep anti-mouse IgG antibodies (Amersham) and TMB peroxidase substrate (KPL). Antibody titers were calculated as the reciprocal of the serum dilution leading to an optical density value at 450 nm equal to five times the background levels.
ELISPOT assay
Spleen cells were collected 3 weeks after virus inoculation and analyzed for the presence of Mengo virus specific CD8+ T cells in a standard ELISPOT assay. Briefly, 96-wells Multiscreen HA nitrocellulose plates (Millipore) were coated with 4 Ag/ml rat anti-mouse IFN-g antibodies (R4-6A2, Becton-Dickinson) in 0.2 M Na-carbonate pH 9.6. Plates were washed and blocked with complete RPMI medium (RPMI 1650 supplemented with 10% FCS, 5 Â 10 À 5 M 2-ß-mercaptoethanol, penicillin 100 U/ml and streptomycin 100 Ag/ml) for 1 h. 10 6 spleen cells from infected mice were then added into the wells along with 5 Â 10 5 irradiated (2000 rad) syngeneic spleen cells as feeder cells, 1 AM VP2 121 -130 synthetic peptide (FHAGSLLVFM, Neosystem) and IL2 (10 U/ml). The cells were incubated for 20 h at 37 -C, and after extensive washes, the spots were revealed by successive incubations with biotinylated rat anti-mouse IFN-g antibodies (XMG1.2, Becton-Dickinson), alkaline phosphatase-conjugated streptavidin (Becton-Dickinson) and 5-bromo-4-chloro-3-indolylphosphate/ nitroblue tetrazolium (BCIP/NBT, Sigma) as the substrate. For each mouse, the number of peptide-specific IFNg-producing cells was determined by calculating the difference between the number of spots generated in the absence and in the presence of the VP2 121 -130 peptide. Results are expressed as the number of spot-forming cells (sfcs) per 10 6 splenocytes.
